INTEST CORP (INTT) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: May 11, 2026

Risk Assessment Details

Potential Dilution: 49.69% of current shares

Recent Dilution: 2.07% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

12M

Potential Supply

6.2M

Additional shares possible

Splits

None

Past 2 years

Summary

INTT currently has 12.4M outstanding shares. with moderate dilution risk from 6.17M authorized shares representing 49.7% potential dilution. The company has minimally diluted shareholders by 2.07% over the past 2 years.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
May 11, 2026	10-Q filing \| 12.4M shares outstanding	12M	6.2M
Mar 12, 2026	10-K filing \| 12.2M shares outstanding	12M	6.4M
Nov 06, 2025	10-Q filing \| 12.2M shares outstanding	12M	6.4M
Aug 07, 2025	10-Q filing \| 12.2M shares outstanding	12M	6.4M
May 08, 2025	10-Q filing \| 12.2M shares outstanding	12M	6.4M
Mar 13, 2025	10-K filing \| 12.2M shares outstanding	12M	6.4M
Nov 06, 2024	10-Q filing \| 12.3M shares outstanding	12M	6.3M
Aug 09, 2024	10-Q filing \| 12.3M shares outstanding	12M	6.3M
May 09, 2024	10-Q filing \| 12.2M shares outstanding	12M	6.4M
Mar 27, 2024	10-K filing \| 11.8M shares outstanding	12M	6.8M
Mar 12, 2024	8-K filing: inTEST Corporation subsidiary, inTEST Italy, Inc., purchased all outstanding capital shares of Alfamation S.p.A. for approximately €20 million, including 187,432 shares of inTEST Corporation common stock and cash.	12M	6.9M
Nov 09, 2023	10-Q filing \| 12.2M shares outstanding	12M	6.4M
Nov 09, 2023	S-3 filing: inTEST Corporation intends to offer and sell common stock, preferred stock, warrants, purchase contracts, rights and/or units for a total proposed amount of $100,000,000.	12M	6.9M
Aug 10, 2023	10-Q filing \| 11.7M shares outstanding	12M	0
May 11, 2023	10-Q filing \| 11.1M shares outstanding	11M	0
Mar 22, 2023	10-K filing \| 10.9M shares outstanding	11M	0
Nov 14, 2022	10-Q filing \| 10.9M shares outstanding	11M	0
Aug 11, 2022	10-Q filing \| 10.8M shares outstanding	11M	0
May 16, 2022	10-Q filing \| 10.8M shares outstanding	11M	0
Mar 23, 2022	10-K filing \| 10.7M shares outstanding	11M	0
Mar 15, 2022	8-K filing: On March 9, 2022, the Board approved the grant of restricted stock to the Company's non-employee directors.	11M	0
Nov 12, 2021	10-Q filing \| 10.8M shares outstanding	11M	0
Aug 12, 2021	10-Q filing \| 10.8M shares outstanding	11M	0
May 13, 2021	10-Q filing \| 10.5M shares outstanding	11M	0
Mar 23, 2021	10-K filing \| 10.2M shares outstanding	10M	67K
Mar 16, 2021	8-K filing: On March 10, 2021, the Board approved the grant of restricted stock to the Company's non-employee directors.	11M	0
Nov 13, 2020	S-3 filing: inTEST Corporation files an S-3 form for a mixed shelf offering of common stock, preferred stock, warrants, and units, with a total proposed amount of $50,000,000.	11M	0
Nov 12, 2020	10-Q filing \| 10.3M shares outstanding	10M	0
Aug 12, 2020	10-Q filing \| 10.3M shares outstanding	10M	0
May 13, 2020	10-Q filing \| 10.2M shares outstanding	10M	0
Mar 23, 2020	10-K filing \| 10.4M shares outstanding	10M	0
Mar 11, 2020	8-K filing: On March 9, 2020, the Board approved the grant of restricted stock to non-employee directors: Steven J. Abrams, Jeffrey A. Beck, Joseph W. Dews IV, and William Kraut, each receiving 9,000 shares of restricted stock.	N/A	0

Back to INTT Details